Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Not applicableStudy completedNCT00745381What this trial is testingA Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine TumorsWho this might be right forGastric CancerPancreatic Cancer Memorial Sloan Kettering Cancer Center 238
Not applicableUnknownNCT03517332What this trial is testingCirculating Tumor DNA Exposure in Peripheral BloodWho this might be right forColorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more Quantgene Inc. 10,000
Not applicableLooking for participantsNCT04090034What this trial is testingPeptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine TumorsWho this might be right forNeuroendocrine TumorsGastroenteropancreatic Neuroendocrine Tumor Methodist Health System 50
Testing effectiveness (Phase 2)Looking for participantsNCT07371663What this trial is testingAn Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsWho this might be right forSolid CancersNSCLC (Advanced Non-small Cell Lung Cancer)Gastric (Stomach) Cancer+2 more Beijing Tide Pharmaceutical Co., Ltd 266
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Very early researchUnknownNCT02823691What this trial is testingThe MetNET-2 TrialWho this might be right forNeuroendocrine Tumors Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 20
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00027534What this trial is testingVaccine Therapy in Treating Patients With Advanced or Metastatic CancerWho this might be right forBreast CancerColorectal CancerGallbladder Cancer+6 more Michael Morse, MD 14
Early research (Phase 1)Study completedNCT03752398What this trial is testingXmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)Who this might be right forMelanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more Xencor, Inc. 198
Testing effectiveness (Phase 2)Ended earlyNCT04260802What this trial is testingEvaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersWho this might be right forCancerNeoplasmsMetastatic Cancer+16 more Ocellaris Pharma, Inc. 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT03228667What this trial is testingQUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsWho this might be right forNon-Small Cell Lung CancerSmall Cell Lung CancerUrothelial Carcinoma+10 more ImmunityBio, Inc. 40
Early research (Phase 1)Active Not RecruitingNCT04007744What this trial is testingSonidegib and Pembrolizumab in Treating Patients With Advanced Solid TumorsWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+19 more Mayo Clinic 36
Not applicableLooking for participantsNCT06356467What this trial is testingInfluence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENsWho this might be right forNeuroendocrine TumorsGEP-NET IRCCS San Raffaele 450
Not applicableEnded earlyNCT04106167What this trial is testingLong-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular ImmunotherapyWho this might be right forAdvanced Solid TumorLymphomaGastric Cancer+15 more Fate Therapeutics 20
Not applicableLooking for participantsNCT07302100What this trial is testingNutritional Status Assessment in Adult Patients Followed for Gastroenteropancreatic Neuroendocrine Tumors at Strasbourg University HospitalWho this might be right forGastroenteropancreatic Neuroendocrine Tumor University Hospital, Strasbourg, France 100
Early research (Phase 1)Active Not RecruitingNCT03833700What this trial is testingE7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)Who this might be right forSolid NeoplasmsColorectal NeoplasmsGastrointestinal Tumors Eisai Co., Ltd. 70